113 related articles for article (PubMed ID: 9412397)
1. [Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
Nonikov VE; Konstantinova TD; Lenkova NI; Minaev VI; Ritchik LA
Antibiot Khimioter; 1997; 42(10):15-8. PubMed ID: 9412397
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and tolerance of coamoxiclav in community-acquired lower respiratory tract infections in children].
Blokhin BM; Aldonina VV; Kozhukhova TM; Nikulin LA; Rumyantsev AG
Antibiot Khimioter; 1997; 42(10):29-32. PubMed ID: 9412400
[TBL] [Abstract][Full Text] [Related]
3. [Coamoxiclav in the empirical monotherapy in outpatients with community acquired pneumonia].
Yakovlev SV; Leshchenko IV; Kolesnikov VV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):19-22. PubMed ID: 9412398
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of lower respiratory tract infections in the elderly].
Komarova VP; Belousov IuB; Sokolov AV; Tishchenkova IF; Efremenkova OV
Antibiot Khimioter; 1997; 42(12):19-24. PubMed ID: 9480649
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
7. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE
J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
Balgos AA; Rodriguez-Gomez G; Nasnas R; Mahasur AA; Margono BP; Tinoco-Favila JC; Sansores-Martinez RH; Hassan M; Beppo O; Wongsa A; Cukier A; Vargas F
Int J Clin Pract; 1999; 53(5):325-30. PubMed ID: 10695094
[TBL] [Abstract][Full Text] [Related]
10. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Wessels F; Anderson AN; Ebrahim O
S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
[TBL] [Abstract][Full Text] [Related]
12. Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
Batard E; Javaudin F; Kervagoret E; Caruana E; Le Bastard Q; Chapelet G; Goffinet N; Montassier E
Clin Microbiol Infect; 2018 Nov; 24(11):1171-1176. PubMed ID: 29964229
[TBL] [Abstract][Full Text] [Related]
13. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
McAdoo MA; Rice K; Gordon GR; Sahn SA
Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group.
Damrikarnlert L; Jauregui AC; Kzadri M
J Chemother; 2000 Feb; 12(1):79-87. PubMed ID: 10768519
[TBL] [Abstract][Full Text] [Related]
16. Amoxycillin/clavulanate prophylaxis in gynecologic surgery.
Triolo O; Mancuso A; Pantano F
Int J Gynaecol Obstet; 2004 Apr; 85(1):59-61. PubMed ID: 15050474
[No Abstract] [Full Text] [Related]
17. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
Yakovlev SV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
[No Abstract] [Full Text] [Related]
18. [Selection of antibacterial therapy for treatment of infections in elderly patients].
Belousov IuB; Komarova VP; Efremenkova OV
Antibiot Khimioter; 1998; 43(10):19-23. PubMed ID: 9825105
[TBL] [Abstract][Full Text] [Related]
19. Hospital antibiotic prescribing and feedback.
Hemeryck L; McGettigan P; Feely J
Br J Clin Pharmacol; 1997 Apr; 43(4):449-50. PubMed ID: 9146861
[No Abstract] [Full Text] [Related]
20. Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections.
Keller C
Diagn Microbiol Infect Dis; 1995; 22(1-2):159-61. PubMed ID: 7587032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
